Standard InChI: InChI=1S/C19H32O4/c1-3-4-5-6-7-8-9-10-11-12-13-14-16-17(18(20)21)15(2)19(22)23-16/h16-17H,2-14H2,1H3,(H,20,21)/t16-,17+/m0/s1
Standard InChI Key: WZYZDHVPSZCEEP-DLBZAZTESA-N
Associated Targets(Human)
DNA polymerase beta 23632 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
KB 17409 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Lu1 576 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
LNCaP 8286 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
ZR-75-1 953 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
HaCaT 4069 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Associated Targets(non-human)
Human immunodeficiency virus type 1 reverse transcriptase 18245 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
DNA 1199 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Molecule Features
Natural Product: Yes
Oral: No
Chemical Probe: No
Parenteral: No
Molecule Type: Small molecule
Topical: No
First In Class: No
Black Box: No
Chirality: No
Availability: No
Prodrug: No
Drug Indications
MESH ID
MESH Heading
EFO IDs
EFO Terms
Max Phase for Indication
References
Mechanisms of Action
Mechanism of Action
Action Type
target ID
Target Name
Target Type
Target Organism
Binding Site Name
References
Properties
Molecular Weight: 324.46
Molecular Weight (Monoisotopic): 324.2301
AlogP: 4.87
#Rotatable Bonds: 13
Polar Surface Area: 63.60
Molecular Species: ACID
HBA: 3
HBD: 1
#RO5 Violations: 0
HBA (Lipinski): 4
HBD (Lipinski): 1
#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.24
CX Basic pKa:
CX LogP: 6.04
CX LogD: 3.04
Aromatic Rings: 0
Heavy Atoms: 23
QED Weighted: 0.30
Np Likeness Score: 1.19
References
1.Kumar KC, Müller K.. (1999) Lichen metabolites. 1. Inhibitory action against leukotriene B4 biosynthesis by a non-redox mechanism., 62 (6):[PMID:10395494][10.1021/np9803777]
2.Kumar KC, Müller K.. (1999) Lichen metabolites. 2. Antiproliferative and cytotoxic activity of gyrophoric, usnic, and diffractaic acid on human keratinocyte growth., 62 (6):[PMID:10395495][10.1021/np980378z]
3.Pengsuparp T, Cai L, Constant H, Fong HH, Lin LZ, Kinghorn AD, Pezzuto JM, Cordell GA, Ingolfsdóttir K, Wagner H.. (1995) Mechanistic evaluation of new plant-derived compounds that inhibit HIV-1 reverse transcriptase., 58 (7):[PMID:7561895][10.1021/np50121a006]
4.Le Lamer AC, Authier H, Rouaud I, Coste A, Boustie J, Pipy B, Gouault N.. (2014) Protolichesterinic acid derivatives: α-methylene-γ-lactones as potent dual activators of PPARγ and Nrf2 transcriptional factors., 24 (16):[PMID:25027935][10.1016/j.bmcl.2014.06.062]